Search details
1.
The Role of Transglutaminase 2 in Cancer: An Update.
Int J Mol Sci
; 25(5)2024 Feb 28.
Article
in English
| MEDLINE | ID: mdl-38474044
2.
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.
Br J Haematol
; 203(2): 224-236, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37495265
3.
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia.
Int J Cancer
; 145(11): 3089-3100, 2019 12 01.
Article
in English
| MEDLINE | ID: mdl-31044428
4.
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.
Br J Haematol
; 178(1): 81-93, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28419476
5.
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
Biomolecules
; 13(4)2023 03 28.
Article
in English
| MEDLINE | ID: mdl-37189352
6.
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.
Cell Death Dis
; 14(10): 704, 2023 10 28.
Article
in English
| MEDLINE | ID: mdl-37898636
7.
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.
J Exp Clin Cancer Res
; 41(1): 64, 2022 Feb 16.
Article
in English
| MEDLINE | ID: mdl-35172855
8.
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(21)2021 Oct 29.
Article
in English
| MEDLINE | ID: mdl-34771616
9.
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia.
Onco Targets Ther
; 13: 9679-9688, 2020.
Article
in English
| MEDLINE | ID: mdl-33061448
10.
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment.
Cancers (Basel)
; 11(12)2019 Dec 04.
Article
in English
| MEDLINE | ID: mdl-31817171
11.
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Clin Lymphoma Myeloma Leuk
; 19(10): 678-685.e4, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31371221
12.
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia.
Oncotarget
; 9(63): 32219-32231, 2018 Aug 14.
Article
in English
| MEDLINE | ID: mdl-30181811
13.
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients.
Eur J Cancer
; 72: 103-111, 2017 02.
Article
in English
| MEDLINE | ID: mdl-28027513
14.
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo.
Cancer Cell
; 31(4): 516-531.e10, 2017 04 10.
Article
in English
| MEDLINE | ID: mdl-28399409
15.
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins.
J Leukoc Biol
; 100(5): 1061-1070, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27312846
16.
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
Oncotarget
; 6(39): 42130-49, 2015 Dec 08.
Article
in English
| MEDLINE | ID: mdl-26517523
17.
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk
; 15(10): 612-20.e1-5, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26233718
Results
1 -
17
de 17
1
Next >
>>